Breaking News Instant updates and real-time market news.

GSK

GlaxoSmithKline

$40.06

-0.315 (-0.78%)

15:52
09/13/17
09/13
15:52
09/13/17
15:52

GlaxoSmithKline confirms FDA panel votes in support of shingles vaccine

GlaxoSmithKline announced that the Vaccines and Related Biological Products Advisory Committee of the U.S. FDA voted unanimously that the data support the efficacy and safety of Shingrix, for the prevention of herpes zoster (shingles) in adults ages 50 and over. FDA Advisory Committees provide non-binding recommendations for consideration by the FDA, with the final decision on approval made by the FDA. GSK's shingles candidate vaccine is not currently approved for use anywhere in the world. Regulatory filings in the European Union, Canada, Australia and Japan are underway.

  • 13

    Sep

  • 13

    Sep

  • 19

    Sep

  • 27

    Sep

  • 24

    Oct

GSK GlaxoSmithKline
$40.06

-0.315 (-0.78%)

09/08/17
MSCO
09/08/17
DOWNGRADE
MSCO
Underweight
GlaxoSmithKline downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Vincent Meunier downgraded GlaxoSmithKline to Underweight saying its 2020 roadmap appears "challenging" given capital allocation constraints and low R&D optionality.
08/30/17
ARGS
08/30/17
NO CHANGE
ARGS
GlaxoSmithKline weakness creates buying opportunity, says Argus
Argus analyst John Eade says that the 8% decline in GlaxoSmithKline's stock over the past quarter has created a buying opportunity. The analyst expects the company's profits to rise by low single percentage digits in 2017 and 2018, and he calls its 5% dividend yield attractive.
07/10/17
PIPR
07/10/17
NO CHANGE
Target $5
PIPR
Neutral
OncoMed termination from GSK not surprising, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff believes GlaxoSmithKline (GSK) terminating its agreement with OncoMed Pharmaceuticals (OMED) is not surprising since tarextumab, the only remaining asset under the collaboration, failed previously to meet the primary endpoint in a Phase II study for first-line small cell lung cancer. The analyst says he remains focused on OncoMed's early stage pipeline including navicixizumab, rosmantuzumab and I/O assets anti-TIGIT and GITR trimer. Tenthoff keeps a Neutral rating on OncoMed with a $5 price target.
07/05/17
07/05/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Capital One (COF) downgraded to Underperform from Neutral at Wedbush with analyst Henry Coffey saying ROE from operations is much lower than expected, and return on capital measures are sub-optimal. 2. Weyerhaeuser (WY) downgraded to Neutral from Buy at BofA/Merrill with analyst George Staphos saying his thesis has played out and catalysts are limited in the intermediate term. 3. Buffalo Wild Wings (BWLD) downgraded to Equal Weight from Overweight at Stephens with analyst Will Slabaugh saying the proxy fight and management shake-up has created uncertainty regarding the company's future and said a downward revision to guidance is likely due to continued margin pressures, soft topline trends, and lack of near-term catalysts. 4. GlaxoSmithKline (GSK) downgraded to Neutral from Buy at Citi with analyst Andrew Baum saying he believes the market is under-appreciating the slowing of the company's HIV market growth. 5. Oneok (OKE) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Tom Abrams saying risk/reward is balanced. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MRO

Marathon Oil

$14.63

-0.425 (-2.82%)

12:05
11/20/17
11/20
12:05
11/20/17
12:05
Options
Marathon Oil call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

CG

Carlyle Group

$21.10

0.05 (0.24%)

12:00
11/20/17
11/20
12:00
11/20/17
12:00
Hot Stocks
Carlyle Group to acquire BenefitMall, terms not disclosed »

Carlyle Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$93.04

-0.57 (-0.61%)

12:00
11/20/17
11/20
12:00
11/20/17
12:00
Recommendations
AbbVie analyst commentary  »

AbbVie price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$17.68

0.025 (0.14%)

11:58
11/20/17
11/20
11:58
11/20/17
11:58
Hot Stocks
New York Times suspends Glenn Thrush following allegations of sexual misconduct »

The New York Times said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
11/20/17
11/20
11:55
11/20/17
11:55
General news
Treasury's $78 B 3- and 6-month bill sale was a little better than average »

Treasury's $78 B 3-…

CBS

CBS

$56.02

-0.72 (-1.27%)

, DISH

Dish

$50.66

0.16 (0.32%)

11:53
11/20/17
11/20
11:53
11/20/17
11:53
Periodicals
CBS: Dish could black out certain programs if pact not reached, Reuters says »

CBS (CBS) warned that…

CBS

CBS

$56.02

-0.72 (-1.27%)

DISH

Dish

$50.66

0.16 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAKE

Cheesecake Factory

$45.44

0.52 (1.16%)

11:50
11/20/17
11/20
11:50
11/20/17
11:50
Options
Cheesecake option volume is 2X daily average as buyers gobble up call options »

Cheesecake option volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
11/20/17
11/20
11:50
11/20/17
11:50
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

SPY

SPDR S&P 500 ETF Trust

$258.20

0.34 (0.13%)

, SPX

S&P 500

11:48
11/20/17
11/20
11:48
11/20/17
11:48
General news
President Trump says U.S. to designate North Korea a state sponsor of terror »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$258.20

0.34 (0.13%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAH

Cardinal Health

$55.62

-1.89 (-3.29%)

, AMZN

Amazon.com

$1,129.88

-7.41 (-0.65%)

11:44
11/20/17
11/20
11:44
11/20/17
11:44
Hot Stocks
Cardinal Health slides as Morgan Stanley says sell on Amazon risk »

Shares of Cardinal Health…

CAH

Cardinal Health

$55.62

-1.89 (-3.29%)

AMZN

Amazon.com

$1,129.88

-7.41 (-0.65%)

PDCO

Patterson Companies

$36.04

-0.03 (-0.08%)

HSIC

Henry Schein

$69.12

-0.39 (-0.56%)

CVS

CVS Health

$70.02

-0.66 (-0.93%)

WBA

Walgreens Boots Alliance

$71.25

-0.05 (-0.07%)

MCK

McKesson

$138.41

-3.72 (-2.62%)

ABC

AmerisourceBergen

$77.22

-1.625 (-2.06%)

TMO

Thermo Fisher

$190.62

0.45 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 28

    Nov

  • 29

    Nov

  • 30

    Nov

  • 12

    Dec

  • 18

    Mar

TRP

TransCanada

$49.73

0.75 (1.53%)

11:42
11/20/17
11/20
11:42
11/20/17
11:42
Hot Stocks
Nebraska approves TransCanada's Keystone XL pipeline »

The Nebraska Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$17.92

-0.29 (-1.59%)

11:40
11/20/17
11/20
11:40
11/20/17
11:40
Options
GE draws a $2.35M call buyer as shares revisit recent lows »

GE draws a $2.35M call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:40
11/20/17
11/20
11:40
11/20/17
11:40
General news
Euro$ interest rate futures trickled lower »

Euro$ interest rate…

CAVM

Cavium

$75.83

-0.47 (-0.62%)

11:33
11/20/17
11/20
11:33
11/20/17
11:33
Downgrade
Cavium rating change  »

Cavium downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

FCAU

Fiat Chrysler

$17.62

0.255 (1.47%)

11:30
11/20/17
11/20
11:30
11/20/17
11:30
Options
Higher option volume in Fiat driven by longer-term call buying »

Higher option volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$46.16

-0.02 (-0.04%)

11:22
11/20/17
11/20
11:22
11/20/17
11:22
Technical Analysis
Technical View: Micron trades to new 52-week highs »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Dec

XOP

SPDR Oil Exploration and Production Fund

$34.45

-0.55 (-1.57%)

11:20
11/20/17
11/20
11:20
11/20/17
11:20
Options
SPDR Oil Exploration and Production puts active »

SPDR Oil Exploration and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
11/20/17
11/20
11:17
11/20/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
11/20/17
11/20
11:16
11/20/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$138.89

-3.24 (-2.28%)

11:15
11/20/17
11/20
11:15
11/20/17
11:15
Options
McKesson put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 29

    Nov

11:15
11/20/17
11/20
11:15
11/20/17
11:15
General news
Treasury announced a $45 B 4-week bill sale for Tuesday »

Treasury announced a $45…

11:15
11/20/17
11/20
11:15
11/20/17
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
11/20/17
11/20
11:15
11/20/17
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:14
11/20/17
11/20
11:14
11/20/17
11:14
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

TCO

Taubman Centers

$54.39

-0.92 (-1.66%)

11:12
11/20/17
11/20
11:12
11/20/17
11:12
Rumors
Rumor moving shares of Taubman Centers »

Rumor: Taubman Centers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.